Pro Test Diagnostics Overview
- Founded
-
2012
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.89M
- Investors
-
5
Pro Test Diagnostics General Information
Description
Operator of a blood doping test laboratory designed to increase performance ability through blood transfusions. The company's test uses reliable, diagnostic anti-doping test kits for autologous blood doping, promote fair and clean competitions using liquid chromatography and mass spectrometry-based proteomics, enabling organizations and test laboratories with the measurements of unique biomarkers for long-term freeze storage of red blood cells, monitor and detect illegal use of one's own stored blood.
Contact Information
Website
www.protestdx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Primary Office
- Tvistevägen 48C
- 907 36 Umea
- Sweden
+46 090-123 00 00
Pro Test Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 08-May-2020 | $1.89M | 00.000 | Completed | Generating Revenue | |
| 3. Corporate | 10-Mar-2015 | Completed | Startup | |||
| 2. Grant | $206K | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Pro Test Diagnostics Patents
Pro Test Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3092425-A1 | Methods for the detection of autologous blood-doping | Pending | 01-Mar-2018 | 000000000 | |
| EP-3759499-A1 | Methods for the detection of autologous blood-doping | Pending | 01-Mar-2018 | 000000000 | |
| JP-2021515249-A | Methods for detecting autologous blood doping | Pending | 01-Mar-2018 | 000000000 | |
| AU-2019228129-A1 | Methods for the detection of autologous blood-doping | Pending | 01-Mar-2018 | 000000000 | |
| US-20200400693-A1 | Methods for the detection of autologous blood-doping | Pending | 01-Mar-2018 | G01N33/80 |
Pro Test Diagnostics Executive Team (4)
Pro Test Diagnostics Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Anders Blom | Pro Test Diagnostics | Chairman | 000 0000 |
| Birgitta Gunneflo | Pro Test Diagnostics | Board Member | 000 0000 |
| Martin Gunhaga | Fort Knox Förvaring | Board Member | 000 0000 |
Pro Test Diagnostics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Pro Test Diagnostics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Nascent Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Fort Knox Förvaring | Holding Company | Minority | 000 0000 | 000000 0 | |
| Umeå Biotech Incubator | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| Vinnova | Government | Minority | 000 0000 | 000000 0 | |
| World Anti Doping Association | Government | 000 0000 | 000000 0 |